Mary's Medicinals Announces Sale of Millionth Transdermal Cannabis Patch

Pioneering Cannabis Company Reaches Patients from Coast to Coast with Award Winning Clinical-Grade Cannabis Products

News provided by

Jun 29, 2016, 08:00 ET

DENVER, June 29, 2016 /PRNewswire/ -- Mary's Medicinals today announced that it has sold its millionth transdermal cannabinoid patch. Recognized by award programs including The Cannabis Business Awards, Cannabis Economy CannAwards, High Times Cannabis Cup and many others, Mary's transdermal products allow medical cannabis patients to consume consistent doses of cannabinoids easily and discreetly.

Mary's Medicinals Transdermal Cannabis Patches (Photo Credit: Alex L. Person)

"When we started making patches in a 400 square foot room three years ago, we knew this technology had the potential to transform how people view and utilize cannabis, but we couldn't have imagined that we'd be able to reach so many patients so quickly," said Nicole Smith, founder & CEO of Mary's Medicinals. "I'm incredibly grateful to our community of customers and supporters as well as our hardworking team for helping us reach this extraordinary milestone."

Available in THC Indica, THC Sativa, THCa, CBN, CBD and CBD:THC 1:1, Mary's flagship patches are born out of a commitment to accurate dosing and the application of advanced delivery methods. Mary's patches are 2x2 squares, easy to use, and adhere simply to any veinous area for all day (or night) relief. Every batch of Mary's Medicinals products is laboratory tested for quality, accuracy and consistency.

Mary's Medicinals established itself as one of the most trusted and innovative producers of canna-based products in Colorado and has since expanded to Washington, California, Oregon, Vermont and Arizona – with launches in additional states planned throughout 2016 and 2017. In order to reach consumers in states without access to full cannabis markets, Mary's Nutritionals offers CBD products (including transdermal patches) to customers in all 50 states, as well as Europe and South America through distribution partnerships.

"The feedback from our customers has been absolutely inspiring. We are truly honored to have such an impact on so many lives, and we look forward to continuing to do everything we can to improve access to quality, tested and trusted products across the country, and eventually, across the world," said Smith.

About Mary's Medicinals:

Mary's Medicinals is a wellness company innovating at the intersection of engineering and horticulture. Mary's is focused on transforming how people view and utilize cannabis, developing trusted products that isolate the benefits of cannabis and other vital plant extracts for optimum patient care. More information is available at: www.marysmedicinals.com

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficiency of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. If you are taking any medication or are under treatment for any disease, please consult your health care professional about potential interactions or other possible complications before using these products. The Federal Food, Drug and Cosmetic Act requires this notice.

Supporting Resources: